Drug makers CV Therapeutics and Astellas Pharma Inc said on Friday the U.S. Food and Drug Administration (FDA) had approved their heart-imaging agent regadenoson, also called Lexiscan. Reuters Health Information
New research suggests aggressive medical malpractice environments do not influence where neurosurgeons practice but may cause them to limit their practice, which may result in a critical erosion of care in some of the most seriously ill neurological patients. Medscape Medical News
The CMS announced that it has expanded coverage for continuous positive airway pressure devices to include those who have been diagnosed with obstructive sleep apnea using home sleep testing. Medscape Medical News
